Cirrhoses, Liver: Clinical Trials

1 trial for Cirrhoses, Liver, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Unknown 1

Follow Cirrhoses, Liver: new trials by email Literature Review of Cirrhoses, Liver trials Research Report on Cirrhoses, Liver

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b
Elbasvir/ Grazoprevir 50/100 mg fixed dose combination - Chronic Hepatitis C Genotype 1B, Metabolic Syndrome
Phase 3UnknownInstitute Of Cardiology & Internal Diseases, Kazakhstan602017-10-012017-08-07

Narrower conditions

Hepatitis C (1)  ·  Liver Cirrhosis (1)  ·  Metabolic Syndrome (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Digestive System Diseases (1)  ·  Fibrosis (1)  ·  Flaviviridae Infections (1)  ·  Glucose Metabolism Disorders (1)  ·  Hepatitis (1)  ·  Hepatitis, Viral, Human (1)  ·  Hyperinsulinism (1)  ·  Infections (1)  ·  Insulin Resistance (1)  ·  Liver Diseases (1)  ·  Metabolic Diseases (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Pathologic Processes (1)

Interventions

elbasvir (1)  ·  grazoprevir (1)

Sponsors

Institute Of Cardiology & Internal Diseases, Kazakhstan (1)

Countries

Kazakhstan (1)